We are live on ! Find out more
ATRC icon

AtriCure

100 hedge funds and large institutions have $551M invested in AtriCure in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

84.64% more ownership

Funds ownership: 0%84.64% (+85%)

32% more capital invested

Capital invested by funds: $417M → $551M (+$133M)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

0% more funds holding

Funds holding: 100100 (0)

Holders
100
Holders Change
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
13
Increased
40
Reduced
34
Closed
12
Calls
$239K
Puts
Net Calls
+$239K
Net Calls Change
-$161K

ATRC Hedge Fund Activity: Q4 2016 in Review

100 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2016, worth a combined $551M — up 32% from $417M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ATRC positions and 12 closed out — a net gain of 1 holder — while 40 added to existing stakes and 34 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $44.1M. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $7.98M sold.

  • 100 institutional investors held AtriCure (ATRC) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $551M of AtriCure stock for Q4 2016, up 32% quarter-over-quarter.
  • 13 funds opened new AtriCure positions in Q4 2016 and 12 closed out, a net change of +1 holder.
  • The largest AtriCure buyer in Q4 2016 was Consonance Capital Management, an estimated $44.1M added.
  • The largest AtriCure seller in Q4 2016 was Massachusetts Financial Services, an estimated $7.98M sold.

Based on aggregated 13F filings for Q4 2016.